Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Taiho to file colorectal cancer combo following positive PhIII data

13.05.2014 / Scripintelligence

TAS-102, an oral combination of trifluridine and tipiracil hydrochloride, met its primary endpoint of overall survival in the Phase III RECOURSE trial. The product increased the lifespan of patients with refractory mCRC whose disease had progressed after…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: